Cel Tuberculosis (TB) remains a major global health problem with 9 million new TB cases and 1.5 million TB deaths in 2013.Given that with a wide health care access to diagnosis, most deaths are preventable, TB mortality is still unacceptably high.With TOPO-TB the aim is to develop the first rapid diagnostic kit based on detection of the activity of an essential enzyme ofthe bacteria. A high degree of simplicity and low cost, in combination with mycobacteria detection in non-sputum samples,will enable TOPO-TB to achieve high impact on Tuberculosis control and elimination. Importantly, the low resourceadaptable format meets the requirements of highly competitive TB test, complementing state-of-the-art methods for detectionat the point of care patient level. Dziedzina nauki medical and health scienceshealth sciencesinfectious diseasesmalariamedical and health sciencesbasic medicineimmunologymedical and health scienceshealth sciencesinfectious diseasesRNA virusesHIVmedical and health sciencesclinical medicinepneumologytuberculosisnatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes Program(-y) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.3. - Treating and managing disease Temat(-y) PHC-12-2015-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Zaproszenie do składania wniosków H2020-SMEInst-2014-2015 Zobacz inne projekty w ramach tego zaproszenia Szczegółowe działanie H2020-SMEINST-1-2015 System finansowania SME-1 - SME instrument phase 1 Koordynator ZYMONOSTICS APS Wkład UE netto € 50 000,00 Adres ABOGADE 15 8200 AARHUS N Dania Zobacz na mapie MŚP Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant. Tak Region Danmark Midtjylland Østjylland Rodzaj działalności Private for-profit entities (excluding Higher or Secondary Education Establishments) Linki Kontakt z organizacją Opens in new window Uczestnictwo w unijnych programach w zakresie badań i innowacji Opens in new window sieć współpracy HORIZON Opens in new window Koszt całkowity € 71 429,00
